DMSO-PDT of BCC - A 6 Year Follow up

Completed

• Conditions: Carcinoma, Basal Cell

• Registration Number: NCT00218829
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

The purpose of this study is to registrate long time clinical and histological treatment response of basal cell carcinoma (BCC) lesions treated with one or two procedures of dimethylsulfoxide supported 5-aminolaevulinic acid photodynamic therapy (DMSO-PDT).

Detailed Description

Not available

Study Timeline

• Study Start: 1997-09
• Primary Completion: 2004-12
• Study Completion: 2004-12
• Study First Submitted: 2005-09-20
• Study First Submitted QC: 2005-09-20
• Study First Posted: 2005-09-22
• Status Verified: 2017-03
• Last Update Submitted: 2017-03-10
• Last Update Posted: 2017-03-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

• histological verified bcc.
• one or two PDT treatments with treatment interval no longer than two weeks.
• lesion complete response three months after therapy.

Exclusion Criteria

• pregnant.
• Gorlin's syndrome.
• morpheaform or pigmented bcc.
• histology older than one year.
• tumour infiltration more than four mm.
• previous PDT treated lesions.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified